59 results
6-K
EX-10.1
BLRX
Bioline Rx Ltd
1 Apr 24
BioLineRx Announces $6 Million Registered Direct Offering
10:35am
laws relating to taxes, environmental protection, occupational health and safety, product quality and safety and employment and labor matters, except … in each case as could not have or reasonably be expected to result in a Material Adverse Effect.
(m) Environmental Laws. The Company and its
20-F/A
2023 FY
BLRX
Bioline Rx Ltd
26 Mar 24
Annual report (foreign) (amended)
4:57pm
business.
We deal with hazardous materials and must comply with environmental, health and safety laws and regulations, which can be expensive … growing our company.
Increasing scrutiny of, and evolving expectations for, sustainability and environmental, social, and governance, or ESG
6-K
EX-99
BLRX
Bioline Rx Ltd
30 Aug 23
Current report (foreign)
6:45am
relating to taxes, environmental protection, occupational health and safety, product quality and safety and employment and labor matters, except … Adverse Effect.
(p) Environmental Matters. (i) No written notice, notification, demand, request for information, citation, summons, complaint or order has
6-K
EX-10.1
BLRX
Bioline Rx Ltd
21 Sep 22
Current report (foreign)
8:00am
, federal, state and local laws relating to taxes, environmental protection, occupational health and safety, product quality and safety and employment … ) Environmental Laws. The Company and its Subsidiaries (i) are in compliance with all federal, state, local and foreign laws relating to pollution
6-K
EX-10.1
izurvzo
3 Sep 21
Current report (foreign)
4:30pm
6-K
EX-99
gkf8p
21 Jan 21
Amended and Restated Underwriting Agreement
4:32pm
6-K
EX-10.1
lrxhzk3pv6ck4u76xf
25 Sep 20
Current report (foreign)
4:33pm
D
0ws2dm
10 Jun 20
$9M in options / securities to be acquired, sold $9M, 6 investors
8:02am
D
r9c9s2 7rnn3krjk0yt4
10 Jun 20
$4.39M in options / securities to be acquired, sold $4.39M, 5 investors
8:00am
6-K
EX-99
gvifq5t0l92f4n3f
3 Jun 20
Current report (foreign)
8:30am
6-K
EX-99
96am2kmj
28 May 20
Current report (foreign)
11:56am
6-K
EX-99
ra1q 20ar
7 Feb 19
As Representative of the several Underwriters
12:00pm
6-K
EX-10.2
ao3e82c9wo 1crzx
3 Oct 18
BioLineRx Increases Stake in BL-8040, its Lead Oncology
6:03am